My Portfolio
+
LINK YOUR PORTFOLIO

Edwards Lifesciences Corp EW:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:47 PM EDT
86.09quote price arrow up+0.09 (+0.11%)
Volume
163,763
Close
86.00quote price arrow down-1.66 (-1.89%)
Volume
4,807,351
52 week range
72.30 - 89.14
Loading...
  • Open87.63
  • Day High87.90
  • Day Low85.81
  • Prev Close87.66
  • 52 Week High89.14
  • 52 Week High Date06/01/26
  • 52 Week Low72.30
  • 52 Week Low Date10/13/25

Latest On Edwards Lifesciences Corp

Key Stats

  • Market Cap49.519B
  • Shares Out575.80M
  • 10 Day Average Volume5.68M
  • Dividend-
  • Dividend Yield-
  • Beta0.86

KEY STATS

  • Open87.63
  • Day High87.90
  • Day Low85.81
  • Prev Close87.66
  • 52 Week High89.14
  • 52 Week High Date06/01/26
  • 52 Week Low72.30
  • 52 Week Low Date10/13/25
  • Market Cap49.519B
  • Shares Out575.80M
  • 10 Day Average Volume5.68M
  • Dividend-
  • Dividend Yield-
  • Beta0.86

RATIOS/PROFITABILITY

  • EPS (TTM)1.84
  • P/E (TTM)46.72
  • Fwd P/E (NTM)28.07
  • EBITDA (TTM)1.914B
  • ROE (TTM)10.52%
  • Revenue (TTM)6.304B
  • Gross Margin (TTM)77.87%
  • Net Margin (TTM)17.02%
  • Debt To Equity (MRQ)5.80%

EVENTS

  • Earnings Date07/22/2026(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

Josh Brown's 'best stocks in the market': Edwards Lifesciences
VIDEO4:4804:48
Josh Brown's 'best stocks in the market': Edwards Lifesciences

Profile

MORE
Edwards Lifesciences Corporation is the global structural heart company. The Company partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. It provides transcatheter heart valve replacement technologies designed for the...
Nicholas Valeriani
Independent Chairman of the Board
Bernard Zovighian
Chief Executive Officer, Director
Scott Ullem
Chief Financial Officer, Corporate Vice President
Theodora Mistras
Corporate Vice President, Chief Financial Officer
Daniel Lippis
Corporate Vice President - Transcatheter Aortic Valve Replacement
Address
One Edwards Way
Irvine, CA
92614
United States